CME Group Inc.
CME- Exchange
- Nasdaq
- Industry
- Security & Commodity Brokers, Dealers, Exchanges & Services
- SEC CIK
- 0001156375
In the last 90 days, CME Group Inc. insiders filed 0 open-market purchases and 2 sales; 1,712 institutions reported holding it in 13F filings for Q2 2026, worth $71.2B in total; 5 superinvestors hold it, including Baupost Group and Viking Global Investors.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CME Group Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $4.26M in total
- Insiders trading
- 2
- Net value
- −$4.26M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CME Group Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Winkler Julie | Sr MD Chief Commercial Officer | 31,561 | Sep 17, 2026 | 2 |
| Vroman Ken | Chief Transformation Officer | 20,232 | Sep 17, 2026 | 3 |
| Tobin Jack J | MD Chief Accounting Officer | 25,762 | Sep 17, 2026 | 3 |
| Sprague Suzanne | COO & Global Head of Clearing | 15,548 | Sep 17, 2026 | 2 |
| Sammann Derek | Sr MD Gl Hd Commodities Mkts | 10,134 | Sep 17, 2026 | 3 |
| McCourt Timothy Francis | Sr MD Global Head Equity & FX | 13,366 | Sep 17, 2026 | 2 |
| Marchese John Clifford | Sr MD, General Counsel | 3,598 | Sep 17, 2026 | 1 |
| Fitzpatrick Lynne | President and CFO | 26,661 | Sep 17, 2026 | 2 |
| Duffy Terrence A | Chairman and CEO | 62,442 | Sep 17, 2026 | 6 |
| Dennis Michael G. | Global Head of Fixed Income | 10,682 | Sep 17, 2026 | 1 |
| Cutinho Sunil | Chief Information Officer | 25,037 | Sep 17, 2026 | 2 |
| Cook Elizabeth A | Director | 17,916Indirect | Sep 14, 2026 | 3 |
| Gepsman Martin J | Director | 25,644 | Jun 29, 2026 | 2 |
| Shepard William R | Director | 260,442Indirect | Jun 29, 2026 | 3 |
| Siegel Howard J | Director | 48,858 | Jun 29, 2026 | 1 |
| Lucas Deborah J | Director | 4,533 | Jun 29, 2026 | 1 |
| Carey Charles P | Director | 6,846Indirect | Jun 29, 2026 | 1 |
| Durkin Bryan T | Director | 43,652 | Jun 29, 2026 | 2 |
| Suskind Dennis | Director | 3,344 | Jun 29, 2026 | 2 |
| Bitsberger Timothy S. | Director | 11,766 | Jun 29, 2026 | 1 |
| Kaye Daniel G | Director | 4,845 | Jun 29, 2026 | 1 |
| Hobert William W | Director | 108,006 | Jun 29, 2026 | 1 |
| Tierney Robert J JR | Director | 14,345 | Jun 29, 2026 | 1 |
| Lockett Phyllis M | Director | 4,285 | Jun 29, 2026 | 1 |
| Ford Harold Eugene Jr. | Director | 2,158 | Jun 29, 2026 | 2 |
| Maloney Patrick W | Director | 4,743 | Jun 29, 2026 | 1 |
| Mulchrone Patrick J | Director | 29,130 | Jun 29, 2026 | 1 |
| Seifu Rahael | Director | 4,739 | Jun 29, 2026 | 1 |
| Benesh Kathryn | Director | 2,752 | Jun 29, 2026 | 1 |
| Piell Hilda Harris | Sr MD & Chief HR Officer | 27,702 | May 19, 2026 | 3 |
| Marcus Jonathan L | Sr MD General Counsel | 7,192 | Mar 23, 2026 | 2 |
| Gerdes Larry G | Director | 36,651 | Apr 28, 2025 | 0 |
| Holzrichter Julie | Sr MD Chief Operating Officer | 40,437 | Sep 17, 2024 | 0 |
| Savage Terry L | Director | 18,189Indirect | Jun 26, 2024 | 0 |
| Glickman Daniel R | Director | 14,756 | Jun 26, 2024 | 0 |
| Tully Sean | Sr MD Global Hd Rates & OTC | 22,087 | Dec 19, 2022 | 0 |
| Pietrowicz John W. | Sr MD Chief Financial Officer | 51,867 | Sep 19, 2022 | 0 |
| Chookaszian Dennis | Director | 4,106 | Jun 29, 2022 | 0 |
| Dutra Ana | Director | 7,176 | Jun 29, 2022 | 0 |
| Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | 41,466 | Mar 17, 2022 | 0 |
| Kometer Kevin | Sr MD Chief Information Office | 63,207 | Feb 14, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 (view filing) | Sep 12 | 1 day | Vroman KenChief Transformation Officer | SSaleCommon Stock Class A | −750 | $201.41 | −$151.1K | −5.7%12.5K after | |
| Sep 12, 2022 (view filing) | Sep 9 | 3 days | Sammann DerekSr MD Gl Hd Commodity & Option | SSaleCommon Stock Class A | −4.00K | $201.51 | −$806.0K | −23.1%13.3K after | |
| Aug 31, 2022 (view filing) | Aug 31 | Same day | Glickman Daniel RDirector | SSaleCommon Stock Class A | −500 | $196.39 | −$98.2K | −3.3%14.6K after | |
| Aug 16, 2022 (view filing) | Aug 15 | 1 day | Piell Hilda HarrisSr MD & Chief HR Officer | SSaleCommon Stock Class A | −4.90K | $203.88 | −$999.2K | −12.9%33.1K after | |
| Mar 14, 2022 (view filing) | Mar 11 | 3 days | Cronin Kathleen MSr MD Gen Counsel & Corp Secr | SSaleCommon Stock Class A | −4.00K | $227.15 | −$908.6K | −9.0%40.4K after | |
| Mar 14, 2022 (view filing) | Mar 14 | Same day | Tully SeanSr MD Global Hd Financial & OT | SSaleCommon Stock Class A | −4.00K | $229.80 | −$919.2K | −18.2%18.0K after | 2 lots |
| Mar 11, 2022 (view filing) | Mar 11 | Same day | Tully SeanSr MD Global Hd Financial & OT | SSaleCommon Stock Class A | −3.00K | $229.00 | −$687.0K | −12.0%22.0K after | |
| Mar 7, 2022 (view filing) | Mar 3 | 4 days | Piell Hilda HarrisSr MD & Chief HR Officer | SSaleCommon Stock Class A | −2.00K | $244.00 | −$488.0K | −5.2%36.4K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Glickman Daniel RDirector | SSaleCommon Stock Class A | −750 | $234.30 | −$175.7K | −5.0%14.3K after | |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Piell Hilda HarrisSr MD & Chief HR Officer | SSaleCommon Stock Class A | −1.50K | $234.01 | −$351.0K | −3.8%38.4K after | |
| Feb 15, 2022 (view filing) | Feb 14 | 1 day | Cutinho SunilSr MD & President CME Clearing | SSaleCommon Stock Class A | −4.90K | $237.96 | −$1.17M | −11.3%38.4K after | |
| Feb 14, 2022 (view filing) | Feb 10 | 4 days | Carey Charles PDirector | SSaleCommon Stock Class A | −3.00K | $244.36 | −$733.1K | −28.1%7.67K after | 2 lots |
| Feb 14, 2022 (view filing) | Feb 10 | 4 days | Cook Elizabeth ADirector | SSaleCommon Stock Class A | −1.00K | $244.25 | −$244.3K | −5.1%18.7K after | |
| Feb 14, 2022 (view filing) | Feb 10 | 4 days | Kometer KevinSr MD Chief Information Office | SSaleCommon Stock Class A | −13.5K | $244.04 | −$3.29M | −17.6%63.2K after | 3 lots |
| Dec 9, 2021 (view filing) | Dec 7 | 2 days | Gepsman Martin JDirector | SSaleCommon Stock Class A | −500 | $231.00 | −$115.5K | −2.1%23.5K after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Sammann DerekSr MD Gl Hd Commodity & Option | SSaleCommon Stock Class A | −4.50K | $226.84 | −$1.02M | −28.3%11.4K after | |
| Nov 15, 2021 (view filing) | Nov 11-12 | 4 days | Siegel Howard JDirector | SSaleCommon Stock Class A | −6.00K | $223.45 | −$1.34M | −7.4%75.0K after | 5 lots |
| Nov 12, 2021 (view filing) | Nov 9 | 3 days | Vroman KenSr MD International & Optimiza | SSaleCommon Stock Class A | −445 | $220.00 | −$97.9K | −3.3%13.1K after | |
| Nov 12, 2021 (view filing) | Nov 10 | 2 days | Bitsberger Timothy S.Director | SSaleCommon Stock Class A | −600 | $221.15 | −$132.7K | −5.6%10.1K after | |
| Nov 12, 2021 (view filing) | Nov 11 | 1 day | Holzrichter JulieSr MD Chief Operating Officer | SSaleCommon Stock Class A | −5.00K | $220.81 | −$1.10M | −12.9%33.7K after | |
| Nov 8, 2021 (view filing) | Nov 5 | 3 days | Durkin Bryan TDirector | SSaleCommon Stock Class A | −10.0K | $222.07 | −$2.22M | −12.8%68.3K after | 3 lots |
| Nov 8, 2021 (view filing) | Nov 5 | 3 days | Duffy Terrence AChairman and CEO | PPurchaseCommon Stock Class A | +400 | $222.02 | +$88.8K | +0.5%81.3K after | |
| Nov 5, 2021 (view filing) | Nov 4 | 1 day | Duffy Terrence AChairman and CEO | PPurchaseCommon Stock Class A | +1.60K | $220.21 | +$352.3K | +2.0%80.9K after | 6 lots |
| Oct 28, 2021 (view filing) | Oct 28 | Same day | Gepsman Martin JDirector | SSaleCommon Stock Class A | −500 | $218.27 | −$109.1K | −2.0%24.0K after | 3 lots |
| Oct 21, 2021 (view filing) | Oct 19 | 2 days | Piell Hilda HarrisSr MD & Chief HR Officer | SSaleCommon Stock Class A | −2.95K | $215.00 | −$633.6K | −6.9%39.9K after | |
| Sep 13, 2021 (view filing) | Sep 13 | Same day | Gepsman Martin JDirector | SSaleCommon Stock Class A | −1.00K | $188.54 | −$188.5K | −3.9%24.5K after | |
| Sep 8, 2021 (view filing) | Sep 7 | 1 day | Gepsman Martin JDirector | SSaleCommon Stock Class A | −1.00K | $194.25 | −$194.3K | −3.8%25.5K after | |
| Aug 30, 2021 (view filing) | Aug 30 | Same day | Gepsman Martin JDirector | SSaleCommon Stock Class A | −1.00K | $201.00 | −$201.0K | −3.6%26.5K after | 3 lots |
| Aug 26, 2021 (view filing) | Aug 24 | 2 days | Tully SeanSr MD Global Hd Financial & OT | SSaleCommon Stock Class A | −5.00K | $200.20 | −$1.00M | −17.6%23.5K after | |
| Aug 23, 2021 (view filing) | Aug 23 | Same day | Gepsman Martin JDirector | SSaleCommon Stock Class A | −1.00K | $201.37 | −$201.4K | −3.5%27.5K after |